//Your Connection to the Life Sciences Industry
Connect to IBC:LinkedIn iconTwitter iconFacebook iconBlog iconRSS icon


Welcome to our products section. Browse a list of current events and courses below. To narrow the list of events by topic, simply click on the relevant link in the left menu.
  • Antibody Engineering & Therapeutics
    December 07-10, 2015
    San Diego Convention Center, San Diego, CA
    IBC's Antibody Engineering & Therapeutics conference is an invaluable resource for your research programs. Attending these meetings means getting important updates from the early stage work of leading academic researchers and tracking the progress of companies advancing antibody therapeutics through clinical development. Covering both cutting-edge developments in the basic science of antibody engineering and clinical/preclinical updates of therapeutic antibodies in development.
  • AsiaTIDES: Oligonucleotide and Peptide Research, Technology and Product Development
    February 24-26, 2016
    Westin Miyako Kyoto, Kyoto, JP
    AsiaTIDES is the leading conference in Asia for global oligonucleotide and peptide leaders to gather under one roof to share the latest groundbreaking science and form successful business collaborations.
  • BioProcess International Conference & Exposition - West
    March 14-17, 2016
    Oakland Marriott City Center, Oakland, CA
    BioProcess International West is your chance to acquire new unique end-to-end solutions that will guarantee you reproducible results and manufacturing success. This how-to environment allows you to focus on your specific development and production challenges in the most effective and efficient ways possible. No matter where you work in the development and production path, you will walk away with the knowledge you need to help you speed development and increase production.
  • TIDES: Oligonucleotide and Peptide Therapeutics
    May 09-12, 2016
    Long Beach Convention & Entertainment Center, Long Beach, CA
    TIDES is the industry's #1 forum for oligonucleotide and peptide leaders to build successful partnerships and accelerate products from early discovery through late-stage development and commercialization.
  • Next Generation Protein Therapeutics
    June 13-15, 2016
    San Francisco, CA
    This conference is the industry's most innovative and comprehensive conference for sharing best practices and new ideas to accelerate the discovery, engineering and development of alternative scaffolds and novel protein therapeutics to create differentiated drugs.
  • Bioconjugates: From Targets to Therapeutics
    June 13-15, 2016
    San Francisco, CA
    This conference focuses on discovery, design, development and CMC manufacturing issues of antibody-drug conjugates and many other types of bioconjugates, in order to facilitate information sharing and help companies move their programs forward.
  • Cell Line Development & Engineering
    June 13-15, 2016
    San Francisco, CA, United States
    The leading forum to gather the global cell line industry together under one roof to actively discuss, understand and utilize these novel techniques and tools.
  • Genome Editing Applications
    June 13-15, 2016
    San Francisco, CA
    IBC's Genome Editing Applications conference will showcase the most up-to-date therapeutic and biomedical applications emerging using CRISPRs, ZFNs, TALENs, AAVs and other genome engineering technologies.
  • Cell Therapy Bioprocessing & Commercialization
    October 05-07, 2016
    Boston Convention and Exhibition Center, Boston, MA
    IBC's Cell Therapy Bioprocessing conference has built a reputation of providing a first-rate faculty of participants, who collectively share perspectives and lessons learned from detailed case studies to help you overcome the challenges, develop the strategies and implement the technologies to propel this field towards commercial sustainability.
  • Next Generation Cancer Immuno Therapies
    October 05-07, 2016
    Boston Convention and Exhibition Center, Boston, MA
    Providing insights on the latest advances in cancer immunotherapies, IBC's Immuno-Oncology meeting will focus on overcoming challenges with discovery, development, approval, and product launch. Discussions will cover methods to improve efficacy, potency, and viability of potential therapeutic candidates.